Tinea Capitis
📧 Sign up to get email alerts when something new happens for Tinea Capitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-03-20FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2020-02-18FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)
The FDA approved a supplemental application for Ketoconazole filed by Thirty Madison Inc, resulting in updates to the Ketoconazole product l…
-
FDA approval · 2018-12-26FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sandoz Inc)
FDA approved a generic version of griseofulvin (Ultramicrosize Griseofulvin) from Sandoz Inc under an Original Application (ANDA 202805) for…
-
FDA approval · 2014-01-09FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Ultramicrosize Griseofulvin tablets from Amneal Pharmaceuticals of New York LLC via an Original Application.
-
FDA approval · 2012-10-22FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sigmapharm Laboratories, LLC)
FDA approved the original application (ANDA) for ULTRAMICROSIZE GRISEOFULVIN from Sigmapharm Laboratories, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-06-28FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Dr.Reddys Laboratories Limited)
FDA approved a supplemental application for terbinafine hydrochloride tablets (250 mg) from Dr. Reddy's Laboratories Limited, authorizing a …
-
FDA approval · 2012-04-10FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
FDA approves Breckenridge Pharmaceutical's supplemental application for terbinafine hydrochloride, a generic antifungal, to market an additi…
-
FDA approval · 2012-02-29FDA Approved: CICLOPIROX — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's ciclopirox as a generic product under an original ANDA application.
-
FDA approval · 2011-12-14FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Terbinafine Hydrochloride by Bionpharma Inc., signaling an approval of a supplemental submission…
-
FDA approval · 2011-09-21FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Terbinafine hydrochloride from NorthStar Rx LLC, updating the generic product's approval.
-
FDA approval · 2010-10-08FDA Approved: GRISEOFULVIN — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Griseofulvin from Cosette Pharmaceuticals in an Original Application (ANDA065438). This approval provides a generic Griseofulvi…
-
FDA approval · 2010-02-16FDA Approved: CICLOPIROX — Original Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved Padagis Israel Pharmaceuticals Ltd's Ciclopirox topical product under Original Application (ANDA 078594), authorizing its m…
-
FDA approval · 2007-07-06FDA Approved: GRISEOFULVIN — Original Application (Actavis Pharma, Inc.)
FDA approved the original application for Griseofulvin as a generic oral antifungal indicated for dermatophyte infections such as tinea capi…
-
FDA approval · 2007-07-02FDA Approved: TERBINAFINE — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s original application for generic terbinafine, expanding access to treatment for fungal infections such as nail…
-
FDA approval · 2007-07-02FDA Approved: TERBINAFINE — Original Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's original ANDA for terbinafine (generic antifungal), enabling a generic terbinafine product to enter the mar…